Cargando…

MRI-Based Tumor Necrosis Depiction in Pancreatic Ductal Adenocarcinoma: Can It Predict Tumor Aggressiveness?

SIMPLE SUMMARY: Pancreatic adenocarcinoma is a leading cause of cancer related deaths worldwide. Since surgical treatment involves serious risk and morbidity, guiding patients appropriately to surgery for only those that stand to benefit is crucial to avoid unnecessary morbidity. Imaging may provide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Mark A., Knipp, David E., Noda, Yoshifumi, Kamran, Sophia C., Baliyan, Vinit, Kordbacheh, Hamed, Hong, Theodore S., Kambadakone, Avinash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136978/ https://www.ncbi.nlm.nih.gov/pubmed/37190241 http://dx.doi.org/10.3390/cancers15082313

Ejemplares similares

Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates
por: Shenoy-Bhangle, Anuradha, et al.
Publicado: (2017)

Imaging guided percutaneous interventions in hepatic dome lesions: Tips and tricks
por: Kambadakone, Avinash, et al.
Publicado: (2017)

Prediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumoral necrosis
por: Noda, Yoshifumi, et al.
Publicado: (2022)

Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma
por: Nishi, Hidemi, et al.
Publicado: (2023)

Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness
por: Rademaker, Gilles, et al.
Publicado: (2018)

Genomic analysis of aggressive ductal adenocarcinoma of the prostate
por: Kobayashi, Hiroaki, et al.
Publicado: (2022)

Pancreatic Collision Tumor of Ductal Adenocarcinoma and Neuroendocrine Tumor
por: Wang, Yuchen, et al.
Publicado: (2018)

Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma
por: Zhao, Xianda, et al.
Publicado: (2016)

Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues in Primary and Metastatic Brain Tumors
por: Zach, Leor, et al.
Publicado: (2012)

Fibrotic Focus in Invasive Ductal Carcinoma: An Indicator of High Tumor Aggressiveness
por: Hasebe, Takahiro, et al.
Publicado: (1996)

The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
por: Zhang, Jingchang, et al.
Publicado: (2022)

Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
por: Smith, Caitlyn, et al.
Publicado: (2022)

Neural Component of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
por: Gola, Michał, et al.
Publicado: (2022)

The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma
por: Ruess, Dietrich A., et al.
Publicado: (2015)

Hypoglossal Nerve Paraganglioma Depicting as Glomus Tumor of Neck
por: Shamsi, Zaid-Ahmed, et al.
Publicado: (2021)

Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma
por: XUE, ZHANXIONG, et al.
Publicado: (2016)

Prognostic value of biomarkers in the tumor microenvironment of pancreatic ductal adenocarcinoma
por: Mishra, Nitish K., et al.
Publicado: (2020)

Pancreatic Ductal Adenocarcinoma: Characteristics of Tumor Microenvironment and Barriers to Treatment
por: Kane, Sujata, et al.
Publicado: (2020)

Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma
por: Sperb, Nadine, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma
por: Lambin, Thomas, et al.
Publicado: (2022)

Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Skorupan, Nebojsa, et al.
Publicado: (2022)

The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
por: Loch, Florian N., et al.
Publicado: (2023)

Translocation of Oral Microbiota into the Pancreatic Ductal Adenocarcinoma Tumor Microenvironment
por: McKinley, Kelley N. L., et al.
Publicado: (2023)

Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma
por: Li, Kexin, et al.
Publicado: (2023)

Dedifferentiated endometrioid adenocarcinoma: An under-recognized but aggressive tumor?()
por: Wu, Emily S., et al.
Publicado: (2013)

Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma
por: Matsushita, Katsunori, et al.
Publicado: (2021)

In vivo Anti‐tumor Efficacy of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α against Tumor Necrosis Factor‐resistant Tumors
por: Tsutsumi, Yasuo, et al.
Publicado: (1996)

Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma
por: Siret, Carole, et al.
Publicado: (2018)

Diagnostic Ability of Methods Depicting Distress of Tumor-Bearing Mice
por: Xie, Wentao, et al.
Publicado: (2021)

Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma
por: Cook, Natalie, et al.
Publicado: (2012)

DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma
por: Azmi, Asfar S., et al.
Publicado: (2019)

Estimation of salivary tumor necrosis factor-alpha in chronic and aggressive periodontitis patients
por: Varghese, Sheeja S., et al.
Publicado: (2015)

Pancreatic ductal adenocarcinoma masquerading as a serous cystic tumor (with videos)
por: Ogura, Takeshi, et al.
Publicado: (2018)

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2019)

A model for the detection of pancreatic ductal adenocarcinoma circulating tumor cells
por: Alexander, Matthew S., et al.
Publicado: (2018)

The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma
por: Herremans, Kelly M., et al.
Publicado: (2022)

Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients
por: Mayado, Andrea, et al.
Publicado: (2020)

Uncovering Tumor‐Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma
por: Yu, Seok‐Yeong, et al.
Publicado: (2023)

The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
por: Wang, Di, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1p4u3o1nj2narbjh8kbh2fme8m